Brainsway Ltd. American Depositary Shares (BWAY)

BrainsWay, a global leader in noninvasive neurostimulation treatments, announces its sponsorship and participation in the Clinical TMS Society's 2025 Annual Meeting. The company will showcase its Deep Transcranial Magnetic Stimulation (Deep TMS) technology, including live demonstrations and new research.

Brainsway Ltd. Sponsored ADR (BWAY) has outperformed the broader Medical sector and its own industry group so far this year, with a year-to-date return of around 45% compared to the sector's average of 8.6%. Another stock, Intuitive Surgical, Inc. (ISRG), has also outperformed the sector.

BrainsWay's (BWAY) latest exclusive multi-year distribution agreement is likely to provide improved patient care in Canada.